HPV Vaccine Cuts UK Cervical Cancer Deaths to Zero

A groundbreaking study shows that a simple vaccine has eliminated cervical cancer deaths in young women across an entire country.

Between 2020 and 2024, not a single woman aged 20 to 24 died from cervical cancer in the United Kingdom. Just two decades earlier, 25 women in that same age group died from the disease every five years.

The game changer was the HPV vaccine, which the UK began offering to teenage girls and boys in 2008. The human papillomavirus is the primary cause of cervical cancer, and this vaccine stops the infection before it can start.

Researchers at Queen Mary University of London studied the impact and found stunning results. Without the vaccine, they expected 23 deaths in young women during those five years. Instead, they recorded zero.

"This is an incredible milestone and major progress in our mission to beat cancer," said Michelle Mitchell, chief executive of Cancer Research UK, which funded the study published in The Lancet medical journal.

Cervical cancer is particularly aggressive and often strikes women under 30. Worldwide, it causes about 350,000 deaths each year, making it the fourth most common cancer in women globally.

The disease develops when certain strains of HPV persist in the body and interfere with normal cell growth. Most people who get HPV clear it naturally within two years, but when high-risk strains stick around, they can cause several types of cancer.

The Ripple Effect

The UK's success story offers hope to countries just beginning to roll out HPV vaccination programs. More than half of African nations now include the vaccine in their national immunization schedules, and vaccination campaigns are expanding across Southeast Asia and Central America.

The vaccine is most effective when given before someone becomes sexually active, which is why most countries target young teenagers. There's no cure for HPV itself, but vaccination prevents the high-risk infections that lead to cancer.

About 660,000 women are diagnosed with cervical cancer worldwide each year, with 94 percent of deaths occurring in low and middle-income countries. The five-year survival rate averages just 67 percent because the disease often goes undetected until it has spread.

India alone recorded nearly 80,000 cervical cancer deaths in 2022. China saw more than 55,000 deaths that same year.

But the UK study proves that HPV-related cervical cancer deaths are preventable with vaccination. As more countries expand access to the vaccine, researchers hope to see similar results replicated around the world, potentially saving hundreds of thousands of lives each year.